OK we are really back.! Following last weeks special with the Women Healthcare Leaders for Progress, the “regular” THCBGang is coming back for the Fall, mostly but not always at the 1pm PT 4pm ET timeslot on Thursdays. Joining Matthew Holt (@boltyboy) on #THCBGang on Friday October 4 at 1pm PST 4pm EST are futurist…
At the cybersecurity pre-conference forum, healthcare leaders discuss privacy standards for secure health data
Every year more than 10,000 taxpayer-supported public housing units are lost to disrepair. But federal lawmakers routinely ignore the full amount, around $115 billion, needed to keep the units in “decent, safe and sanitary” condition. One-time funds for public housing repairs were cut from the final version of the 2022 Inflation Reduction Act to appeal…
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
Implementing patient flow technology ultimately enhances operational efficiency and improves the overall patient experience, making it essential for healthcare organizations aiming for better outcomes, improved capacity management, and greater financial stability. The post From Admission to Discharge: How AI Reduces Hospital Length of Stay appeared first on MedCity News.
Philips is showcasing its partnerships and new products at RSNA 2024, including an expanded collaboration with AWS and a CT scanner that the company said uses up to 80% less radiation than traditional systems. The post 3 Innovations Philips Is Showcasing at RSNA 2024 appeared first on MedCity News.
UPMC Enterprises and Redesign Health launched a new startup named Glimmer Health. The company partners with primary care providers to improve pain management using a personalized, holisitic approach. The post UPMC Enterprises, Redesign Health Launch New Startup for Chronic Pain Patients appeared first on MedCity News.
Crescent Biopharma is going public via a reverse merger with GlycoMimetics that will capitalize the combined company with $200 million. Crescent’s lead program is a bispecific antibody for cancer that replicates the properties of a Summit Therapeutics bispecific drug that recently trounced Merck’s blockbuster med Keytruda in a pivotal head-to-head study. The post Going In…
Our goal should be to make lymphedema a preventable aspect of cancer survivorship or at a minimum, manageable, rather than a debilitating aftereffect that diminishes patients’ quality of life. The post Revolutionizing Breast Cancer Survivorship Care: Early Detection and Prevention of Lymphedema appeared first on MedCity News.